Cardiology Flashcards
BB CIs
1- Asthma
2- HR <50 without pacemaker
3- Recent <4w or acute CHF exacerbation PLUS Cardiogenic shock or flash Pulmonary edema
- Use with caution (not preferred) in patients with BP <90/60 or HR 50-59
Peripartum Cardiomyopathy Treatment
1- Ferusmide till euvolemic
2- BB once euvolemia established
Pulse pressure definition
Systolic - Diastolic
Pulse pressure in advanced HF
Narrow
Pulse pressure range
40-60 mmHg
Weight in advanced HF
Weight loss ( catabolic state )
HFpEF >40%, best medication for mortality
MRA (spironolactone), with careful attention to serum K+
Carvedilol maximum therapeutic dosage
25mg BID
BNP
NT-proBNP and BNP ranges differes across age groups
Five drug classes may worsen CHF and therefore should be avoided?
1- CCB (except amlodipine)
2- NSAIDs
3- TZD (pioglitazone)
4- inhaled anesthetics
5- Some antidepressants (SSRI may be used judiciously )
Whats the most common type of Paroxysmal SVT?
AVNRT [Atrioventricular Nodal Reentrant Tachycardia]
- common among women and young adults
Second most common type of Paroxysmal SVT?
- AVRT ( Atrioventricular Reciprocating Tachycardia )
Most common type in childrens
Acute pericarditis most common cause
More than 90%: idiopathic or viral
First line treatment for acute pericarditis
- NSAIDS
- Indomethacin may reduce myocardial perfusion, therefore not preferred in patients with CCS OR ACS
- 2nd line: Colchicine, alone or in combination with NSAIDs
Steriod: shown to increase risk of recurrent pericarditis
Therefore, not preferred, unless indicated
JNC 8, when to start Anti-htn according to age
Older than 60: 150/90
Younger, DM, or CKD: 140/90
When to decide to add on or increase dose of anti HTN?
- if target BP not reached within 1 month
First line antihypertensive in CKD and DM nephropathy
ACEI
Anti htn for COPD patients
Selective BB is the agent of choice. Reduce mortality and COPD exacerbation
Mention two selective B1 BB?
- Bisoprolol
- Metoprolol
BB B1 Selective safer in whom?
- Diabetic with PAD
- Asthma and COPD
Anti HTN in pregnancy
- labetalol 1st line
- Nifedipine, methyldopa
Anti HTN for recurrent stroke prevention
ACEI and thiazide diuretic
When to stop ACEI in CKD?
Raise in creatinine >30% > should prompt investigations to renal artery stenosis
Strongest clinical evidence among Thiazide diuretics?
- Chlorthalidone
- All thiazide most effective when combined with ACEI
Monitor for Hypokalemia
Loop diuretic may be needed if eGFR <40
Preferred ARBS in gout and hyperuricemia
- Losartan
Preferred ARBS in migraine patients
Candesartan
BB for DM SE
Mask hypoglycemia awareness
Adversly affect glucose
CCB classes
Di-hydro-pyridine: Amlodipine, nifedipine,
Non- Di-hydro-pyridine: diltiazem, verapamil
Can di-hydro-pyridine combined with BB?
YES
But Non dhp ccb is CI, due to redueced HR and heart block SE
Vasodilators in HTN
Hydralazine and Minoxidil: may cause reflex tachycardia (needs BB), and fluid retention (needs diuretic)
Alpha blockers as doxazosin, terazosin: orthostatic hypotension
Centrally acting agent for HTN
Clonidine (available as weekly patch). Methyldopa, guanfacine
What features suggest secondary HTN
1- <40 yo with grade 2.
2- Childhood with any grade
3- Resisitant
4- Extensive HMOD
BB in pheochromocytoma?
Will increase BP
When to initiate high intensity statin?
1- LDL 190
2- ASCVD 10year risk 20%
When to initiate moderate intensity statin?
- 40-75 and Diabetic
- 40-75 and LDL 70-189 and ASCVD risk is 7.5-<20% “intermediate risk” + risk enhancers favoring statin
- 40-75 and LDL 70-189 and ASCVD risk is 5-<7.5% “borderline risk” + risk enhancers favoring statin then DISCUSS “class 2b (mainly lifestyle and risk factors management)
Low risk (<5%) is always for lifestyle risk factors decreasing
USPTF: 40-75 + ASCVDA RISK >10%
What is risk decision is uncertain?
Consider measuring CAC in selected patients
CAC: 100 initiate statin
CAC: 1-99 Favoring statin specially after age 55
CAC: zero no statin (unless family history of premature CHD or smoker)
What are high intensity statins?
Atorva 40
Rosuva 20
What are moderate intensity statin
- Lova 40
- Atorva 20
- Simva 20
- Rosuva 10
Mention the ASCVD Risk enhancers?
- Family history of premature ASCVD (55 MALE, 65 FEMALE)
- CKD
- Metabolic syndrome
- Premature menopause
- Preeclampsia
- inflammatory disease ( specially HIV, RA, PSORIASIS)
- Ethnicity
Lab:
- Persistently elevated TG 175. Or LDL 160
Age 0-19 with dyslipidemia
- lifestyle
- statin if familial
Age 20-39 with dyslipidemia
- lifestyle
- Consider statin if FH of premature CVD PLUS LDL 160
Mechanism of action of statin?
Inhibit HMG-CoA Reductase > this leads to increase activity of LDL receptors on liver
Mechanism of action of Fibrates?
- Increase Lipprotein lipase activity
PE in dyslipidemia
1- Orange large tonsils, intermittent neuropathy, hepatosplenomegaly, very low HDL and TC, yellow mucosa, conreal opacitiy: Tangier disease
2- Eruptive xanthoma: chylomicronemia syndrome “TG from 1500 to 2000”
3- Tendinous xanthoma, arcus juvelinis: Familial hypercholesteremia
JNC-8 BP targets
60 years old: 150/90
<60 even if CKD or DM: 140/90
When to refer HTN?
uncontrolled on more than THREE drugs
Orthostatic hypotension definition
Fall in systolic 20mmHG
Fall in diastolic 10mmHG
5 minutes set or supine
Then 2-3 minutes upright
Orthostatic hypotension causing medications?
Antihypertensive and diuretics
Hypertension emergency goals?
- MAP 10-20% in the first hour
- MAP 5-15% over 23 hours
MAP REDUCTION >25% may cause end organ ischemia
Exception for gradual reduction of BP over a course of one day in hypertension emergency
1- Ischemic stroke
2- ICH
3- Aortic dissection
What IV antihypertensive increase renal perfusion?
FENOLDOPAM ( Dopamine-1 reception agonist)
USPSTF HTN screening
18 years old, every 3-5 years
At least yearly IF: Age >40, risk factors (obesity) or prehypertensive (120-129 systolic) twice a year
Elbow Xanthoma versus Eruptive Xanthoma
Elbow Xanthoma: LDL >300
Eruptive Xanthoma: LDL >1000
First line agent to prevent Pancreatitis In HyperTriglycermia of 500mg/dL or more
FIBRATE (Gemfibrozil)
Mild to moderate elevation (>150 but >500): lifestyle and consider statin based on ASCVD risk assessment
Severe elevation (>500): FIBRATE
If still uncontrolled FIBRATE + OMEGA3 FATTY ACID
What age group more responsive to ACEI and ARBS?
<50 YEARS OLD
Clonidine mechanism of action
Centerally acting presynaptic Alpha-2 adrenergic agonist
Decrease sympathitic response
Calcium channel blockers
NON-DiHydroPyridine is Dilitizam and veraprimil
NON = NON BEAT = HEART BLOCK
Most frequent electrolyte abnormality with thiazides diuretic?
Hypokalemia
First line antihypertensive in CKD?
ACEI or ARBS
REGARDLESS OF AGE (EVEN IF BLACK)
The only exception is those who aged 75 or older with reduced renal function ( fear of Hyperkalemia and increased creatinine )
Cardiogenic shock
Narrow pulse pressure
LOW cardiac index
HIGH pulmonary capillary wedge
The only shock with HIGH Mixed venous oxygen (SvO2) IS?
SEPTIC SHOCK
Most common cause of cardiogenic shock
ACUTE MI
Best antihypertensive for GOUT?
- Losartan
Diuretics (thiazide and ferusmide) increase urate reabsorption
Most common cause of drug-resistant hypertension?
Primary hyperaldosteronism
Treatment of Conn?
Adenoma: surgery
Hyperplasia: sprinolactone
Septic shock treatment
Measure and follow lactate level
1- fluid (30cc/kg)
2- Norepenphrine if MAP still <65
3- vasopressin
Septic: Norepenphrine, Dopamine
Cardiogenic: Dubtamine
SIRS?
Temp: >38, <36
HR: >90
RR: >20
WBC: >12000 or less than 4000
First line for orthostatic hypotension
Lifestyle: water intake, smaller meal with less carbs, avoid alcohol, isometric and lower extremities exercise, stand up slowly, avoid overheating
Fludrocortisone, Midodrine (alpha-1 agonist), Pyridostigmine
CCB with greater effect on AV node?
Verapamil
Polycystic kidney disease
- AD
- ACEI or ARBS
- Family history
- PKD1 gene
- U/S
- flank pain or hematuria
- Most common inherited cause of CKD
- Tolvaptan (large kidney volume or decline in GFR)
- Increased risk of liver involvement, berry aneurysm, and inctracerebral haemorrhage
Postural tachycardia syndrome
Raise in HR >30bpm with standing
Absence of orthostatic hypotension
Treatment: fluid and salt intake and structured exercise therapy, usually resolved within 6 weeks
When to start combined antihypertensive?
Systolic >20mmHg or diastolic >10mmHG above target
Meaning:
18-59: >160/100
60: >170/100
RAS management ( renal artery stenosis )
- ACEI or ARBS are first line
- Percutanous angioplasty
- Surgical revasculization
Compelling indications?
Stable angina: BB, CCB
Atrial flutter/fibrillation rate control: BB, NON-CCB
Systolic HF, POST MI, CKD: ACEI
BPH: ALPHA BLOCKERS
ESSENTRIAL TERMOR: NON SELECTIVE BB
HYPERTHYRODISM: BB
Antihypertensive CI
Angioedema: ACEI
Asthma: BB
Depression: Reserpine
Liver disease: Methyldopa
Pregnancy: ACEI, ARBS
Second or third degree Heart block: BB, NON-CCB
Antihypertensive adverse effect on comorbid conditions
Depression: BB, and colondine
Gout: diuretics
Hyperkalemia: ACEI and ARBS
Hypokalemia and Hyponatermia: Thiazide
Renovascular disease: ACEI and ARBS
Hypertensive emergency special drug indication
- Vasodilators:
Nitruprusside: combine with BB to avoid reflex tachycardia
Nicradipine: caution with CAD and CHF
FENOLDOPAM: Caution with glaucoma
Nitroglycerin: PREFERRED IN CORONARY ISCHEMIA
Hydralazine: ECLAMPSIA
Enalaprilat: preferred in Acute HF. Avoid in Acute MU
- Adrenergic inhibitors:
Labetalol: Caution in AHF
Esmolol: AORTIC DISSECTION
Phentolamine: PHEOCHROMOCYTOMA
Goal of BP in Ischemic stroke?
- <220/120 if not candidate for tPA
- <185/110 if candidate for tPA
What BB doesn’t carry risk of Predm and dm?
Carvedilol and Nebivolol
What condition necessitates the most RAPID correction of blood pressure?
AORTIC DISSECTION
WITH A GOAL OF 100-120 SYSTOLIC WITHIN 20 MINTUES
BB first to reduce HR <60.
HF classification
HFrEF: EF of 40% or lower
HFpEF: EF of 50% or more
(HF with borderline preserved ejection fraction is 41 to to 49, it is a definition, but treatment and outcome is the same HFpEF)
Most common cause of HF?
IHD
Most common cause of right HF
Left HF
Rule of BNP
Distinguish cardiac from pulmonary etiology of dyspnea
Gold standard test for HF?
TTE
Most common cause of HFpEF?
Hypertension
Advanced HF laboratory marker?
Hyponatermia
NT Pro-BNP
Also elevated in CKD
Albumin in advanced HF
LOW (<3.4mg/dl)
NYHA classes
Class 1: No limitation - Asymptomatic
Class 2: Slight limitation - Mild symptoms with ordinary activities
Class 3: Moderate limitation: Symptoms with minimal activity
Class 4: Severe limitation - Symptoms at rest
HFrEF classes guided treatment
ACEI:
Class 1 or more
BB:
Class 2 or more
Spirnolactone:
Class 3 or more if EF<35%
Hydralazine plus nitrate:
- Class 2 or more
- Black or cannot tolerate ACEI and ARBS
Does SGLT-2 have mortality benefit in HFrEF?
Reduced hospitalization
Initially diagnosed HFrEF and volume overload
- Ferusmide is mandatory
- Initiate ACEI during or after optimization of Ferusmide
HFrEF and CCB?
Amlodipine, and felodipine are particularly safe if given for HF but with other indication (HTN, Angina)
BB that carry mortality benefit in HFrEF?
- Metoprolol Succinate ER
- Bisoprolol
- Carvedilol
Ferusmide mechanism of action?
- Inhibit reabsoprtion of Na+, K+, and Cl-
- Common electrolytes abnormalities with Loop Diueretics: Hypo N+, k+, Mg+
BNP for HF, High positive or negative predictive value?
High Negative predictive value
So a low BNP helps to r/o heart failure
Sensitive, but not specific
Strong predictor of mortality in 2-3 months, but monitoring in OPD is useless
All cardiac disease can elevate BNP and NT-proBNP
Non cardiac causes:
- advanced age
- anemia
- renal failure
- pulmonary; OSA, severe pneumonia, embolism, P.HTN
- Sepsis or critical illness
- severe burn
S3 versus S4 in heart failure?
S3 early diastole: Systolic HF (HFrEF) - may be normal
S4 late diastole: Diastolic HF (HFpEF) - always abnormal
Medications used for HFpEF?
- SGLT-2: Mortality benefit, and reduce hospitalization
- MRA (spirnolactone): reduce hospitalization, with less clear mortality benefit
Others are usually not indicated since there’s no benefit including (ACEI, BB, Nitrate and hydralazine)
Recommendations for SGLT-2i in HFrEF??
Reduce hospitalization in patients with HFrEF + DM + established or high risk ASCVDs
Diastolic HF versus Systolic HF?
Diastolic: Reduce active ventricular relaxation and Reduce passive ventricular compliance
Three most common causes of HFpEF?
IHD
HTN
VHD
Pericardial effusion versus Cardiac temponade
- Can occurs from right sided HF
- ECG:
Start with effusion > sinus tachycardia with low voltage QRS complex > effusion progress > Cardiac tamponade > Electrical alternans ( alternating high and low QRS complex amplitudes between beats ) - Echo in cardiac tempondae:
Diastolic collapse of right ventricles ( HIGHLY SENSITIVE AND SPECIFIC )
Early systolic collapse of Right atrium (less sensitive but very specific)
Plethoric IVC
- Management:
Saline bolts (cuz patient is preload dependant)
Pericardiocentesis
Pericardial window
Two non-pharmacological treatments help to reduce mortality in HFrEF?
Disease management and Telemonitoring
AHA/ACC HF classification
Stage A: High risk - No symptoms or structural disease
Stage B: Structural disease - No symptoms
Stage C: Structural disease + Symptoms
Stage D: Refractory HF
How to estimate left atrial pressure?
Swan Ganz Catheter ( Pulmonary Artery Catheter )
Leading cause of 2ndry healthcare-associated bacteremia?
UTI associated with Urinary Catheter
CCB and HF?
Non-hydropyridine is not permitted “negative iontropic effects”
Hydropyridine, such as amlodipine, has no rule in HF, but can be used if additional management of HTN is needed. Not indicated if EF is 30% or less
Hydrochlorothiazide and HF?
If patients has insuffienct response to loop “inhibit sodium reabsorption at loop of henle”
Thiazide combined to loop have increased efficacy “inhibit remaining sodium reabsoprtion at distal tobules”
*Monitor for Hypokalemia if combined
Which Antiobiotics should be avoided or carefully monitored in patients with HF?
- TRI-Sulphate (BACTRUM)
Risk of HYPERKALEMIA
Prinzmetal angina
Occur without precipitating factor and associated with ST ELEVATION
Premature CVD
Men <55
Women <65